Israel Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Changes are afoot at Blogtrottr! By popular request, we're bringing in paid plans with some cool new features (and more on the way). You can read all about it in our blog post.

Life Sciences Market Research Reports

Israel Pharmaceuticals and Healthcare Report Q3 2013 Jul 3rd 2013, 00:00, by jitu BMI View: This quarter has seen the health ministry’s commitment to developing the biotechnology sector demonstrated by its decision to fast-track stem cell therapy candidate NurOwn, discovered by local company Brainstorm Cell Therapeutics, through early stage clinical trials. It is indicative that there is flexibility in perceived long clinical trial approval times granted by the government in developing and commercialising locally-produced biotechnology products, one of the key deterrents to investment in the country. Headline Expenditure Projections ? Pharmaceuticals: ILS7.39bn (US$1.92bn) in 2012 to ILS7.76bn (US$2.15bn) in 2013; +5.0% in local currency terms and 12.4% in US dollar terms. Forecast broadly … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=105183. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/israel-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions